Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials
Novartis ($NVS) stock rose about 6% at the time of writing on Tuesday, after the Swiss drugmaker reported positive results from two late-stage tria...
Sanofi Aventis (SNY)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 10,627,088 | $453,351,578 | -8% | 0.13% |
| 2. | Millennium Management Israel Englander | 3,727,890 | $159,031,787 | +9% | 0.06% |
| 3. | VGI Partners Robert M. P. Luciano | 2,653,974 | $113,218,530 | +5% | 6.25% |
| 4. | Balyasny Asset Management Dmitry Balyasny | 2,405,640 | $102,624,602 | +189% | 0.13% |
| 5. | Alyeska Investment Group Anand Parekh | 2,112,012 | $90,098,432 | -9% | 0.23% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 28,088,274 | $1,198,245,769 | 0.63% | |
| 2. | 10,702,527 | $456,569,944 | 0.02% | |
| 3. | 8,008,572 | $341,645,673 | 0.02% | |
| 4. | 6,798,961 | $290,043,700 | 0.02% | |
| 5. | 6,573,682 | $285,495,097 | 0.02% |
News See All
Why the Amlitelimab Setback Isn't Enough to Sink Sanofi's Multi-Billion Dollar Engine
It was reported on July 24 that Sanofi (NASDAQ:SNY) shares underperformed in European trading following the company’s decision to drop the clinical development of its eczema candidate, amlitelimab, ...
Antipodes Exited Sanofi (SNY) After Repeated Pipeline Setbacks
Antipodes Partners published its "Antipodes Global Strategy" second-quarter 2026 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook.
10 Best Dividend Stocks Yielding at Least 5% to Buy According to Hedge Funds
In this article, we will highlight 10 Best Dividend Stocks Yielding at Least 5% to Buy According to Hedge Funds. Expect strong market gains heading into the second half of the year.
Deutsche Bank Cuts PT on Sanofi (SNY) - Here's Why
Sanofi (NASDAQ:SNY) is one of the best low volatility stocks to buy under $50.
12 Best NASDAQ Stocks to Buy for Dividends
In this article, we are going to discuss the 12 best NASDAQ stocks to buy for dividends.
10 Best Low Volatility Stocks to Buy Under $50
In this article, we will look at the 10 Best Low Volatility Stocks to Buy Under $50.
Is Sanofi (SNY) A Good Stock To Buy Now?
Is SNY a good stock to buy? We came across a bullish thesis on Sanofi on r/ValueInvesting by stefanliemawan. In this article, we will summarize the bulls’ thesis on SNY.
Is Sanofi (SNY) Approaching a Breakthrough in Rare Neurological Disease Treatment?
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Sanofi (NASDAQ:SNY) is among the most undervalued stocks to invest in.
11 Most Undervalued Pharma Stocks to Invest In
In this article, we will be taking a look at the 11 Most Undervalued Pharma Stocks to Invest In.
Hedge Fund Resource Center